XIST and ovarian cancer: Furthermore, the oxidative phosphorylation pathway (OXPHOS), which is highly used by CSC (2), was enriched in OVCAR3-KRAB cells with XIST KD as well as in TCGA ovarian cancer patient samples (Fig. 3 C and D).